Drug Type Small molecule drug |
Synonyms BMS 275183 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC43H59NO16 |
InChIKeyAHXICHPPXIGCBN-GPWPDEGDSA-N |
CAS Registry355113-98-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United States | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Belgium | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Canada | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | France | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Italy | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Netherlands | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Spain | 01 Jul 2006 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United Kingdom | 01 Jul 2006 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 Oct 2004 | |
Advanced Malignant Solid Neoplasm | Phase 1 | Belgium | 01 Oct 2004 |